Imrab® + PotomavacTM
Neorickettsia risticii Bacterin
Equine POTOMAVACTM + IMRAB® contains inactivated rabies virus combined with an inactivated suspension of Neorickettsia risticii
Recommended for the vaccination of healthy horses against rabies virus and potomac horse fever
Safety and efficacy of the vaccine has been demonstrated in controlled tests and through field evaluation
Inactivated rabies virus and inactivated suspension of Neorickettsia risticii combined in one dose (1mL)
Safety and efficacy has been demonstrated in controlled tests and through field evaluation
Safe for use for healthy horses, 3 months of age or older
- The duration of immunity against rabies is at least one year
Shake well before use. For primary vaccination, aseptically inject 1mL (1 dose) intramuscularly (IM) into healthy horses 3 months of age or older.
For Neorickettsia risticii, revaccinate with a second 1mL dose intramuscularly 3 or 4 weeks later using this product or PotomavacTM.
Revaccinate annually with a single 1 mL dose of Imrab®+PotomavacTM.
Store at 2-7 ̊C (35-45 °F)
Do not freeze
Do not mix with other products
Use entire contents when first opened
Do not vaccinate within 21 days before slaughter
This product has not been tested in pregnant mares
In case of human exposure contact a physician
In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. Vaccinating animals whose immune response is compromised by stress, disease, etc. may not produce the desired results.
For veterinary use only.
POTOMOVAC TM is a trademark of Boehringer Ingelheim Animal Health USA Inc.
IMRAB® is a registered trademark of Boehringer Ingelheim Animal Health USA Inc.
©2021 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved.